Glyco-engineering in plants to produce human-like N-glycan structures.
about
Putting the Spotlight Back on Plant Suspension CulturesTackling Unwanted Proteolysis in Plant Production Hosts Used for Molecular FarmingBiomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applicationsPlants as Factories for Human Pharmaceuticals: Applications and ChallengesPlant-made vaccines against West Nile virus are potent, safe, and economically feasibleExpression and glycoengineering of functionally active heteromultimeric IgM in plants.Human Alpha Galactosidases Transiently Produced in Nicotiana benthamiana Leaves: New Insights in Substrate Specificities with Relevance for Fabry DiseaseBiological significance of complex N-glycans in plants and their impact on plant physiologyCharacterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco.Plant glyco-biotechnology on the way to synthetic biologyHigh-level transient expression of ER-targeted human interleukin 6 in Nicotiana benthamianaGeneration of biologically active multi-sialylated recombinant human EPOFc in plants.Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana.A combined system for engineering glycosylation efficiency and glycan structure in Saccharomyces cerevisiaeEndo-F3 Glycosynthase Mutants Enable Chemoenzymatic Synthesis of Core-fucosylated Triantennary Complex Type Glycopeptides and Glycoproteins.Efficient Production of a Bioactive Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in Transgenic Rice Callus.Chemical and chemoenzymatic synthesis of glycoproteins for deciphering functions.Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologueMolecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins.Trafficking of endoplasmic reticulum-retained recombinant proteins is unpredictable in Arabidopsis thaliana.Antibodies from plants for bionanomaterials.Humanizing glycosylation pathways in eukaryotic expression systems.Vacuolar targeting of recombinant antibodies in Nicotiana benthamianaStructural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants.Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycans.Expression of functionally active sialylated human erythropoietin in plantsEditorial: from plant biotechnology to bio-based products.Multiplexed, targeted gene editing in Nicotiana benthamiana for glyco-engineering and monoclonal antibody production.N-glycan maturation mutants in Lotus japonicus for basic and applied glycoprotein research.Transient Expression of Mammalian Genes in N. benthamiana to Modulate N-Glycosylation.Production of complex viral glycoproteins in plants as vaccine immunogensProteolytic and N-glycan processing of human α1-antitrypsin expressed in Nicotiana benthamianaImproving Immunotherapy Through Glycodesign
P2860
Q26750974-61D15D07-4DAE-4705-A3E6-EB6AA1B6E1ABQ26750988-37BD86C3-4CD6-4E72-930D-907C0744C539Q26766215-E3FE212B-1339-4A26-AD51-3F1DFA08F1A3Q26775069-6F3B5BFF-A1D2-43E7-A351-F2C90AD0AE0DQ28082778-0E449216-5889-473D-8E3C-89CA5BC09595Q30412932-A3465F40-A8BB-49EB-ABD6-59E1E3081B68Q33819347-6F388B73-19B6-4C69-8447-81776C5B023FQ33928774-F6C25891-3DC4-47EF-84D5-C36397AC1353Q33957908-BA279E89-B2BD-496E-BE9C-27A784FAE8E6Q34304795-72E267B7-4DA9-4C09-BF75-E93EF4DFC5CFQ34477570-C8DA794C-8D8D-4958-B52E-18C22FD2710BQ34571378-77C44581-BF3D-408E-AEA0-39A4F31CFD05Q34693466-F289568C-9DD3-4109-BA5B-2B0019467731Q36598969-C6C79C90-7055-4871-87F1-FE9EDEF1BBD5Q36884884-C9B67D82-FB65-4087-B955-29E873752679Q37159302-523D19C3-6BD7-4E08-B6F8-C0F8FE2CBB75Q37581781-4D29E4D1-61F2-4B61-8F5E-0D47CA619CA7Q37684636-97A3608F-5F74-4C83-90BC-5529FAEF3663Q38174581-D63230ED-8E57-498B-952F-8A1079720986Q38259569-F9E1ECAE-C15D-4466-8DCE-9CD02586D1B6Q38739385-48E06F9F-1F1B-454B-ABAD-9C33A9842C39Q39006079-677B3730-C805-4AF1-825B-FBF158EBCB6FQ39783061-962752E1-A79B-461D-A691-FEC4B2334512Q40201894-7DDC34D0-A51C-4165-8EE7-CE32F1F15AC3Q41512598-9D9C8DE0-5554-4DC1-976B-6F64EB79486EQ42229402-489B01B8-538A-4839-95D0-2DF95CDCEA6EQ44276704-EDE8A1B9-29E8-4D0D-B5DA-480A87E27663Q47929562-0A73B681-AD9D-4D22-8FBA-02DE6B400CB7Q50917741-859DC221-7C42-46E0-84A4-92CF00083E90Q51626867-6BBFEE6A-A86D-4FC5-B156-C6B6763DDDEEQ56398263-7A7B89DD-973B-4B26-8E91-EFDF892FEC19Q56974439-DAAB66A4-5A3F-4AF0-BDB3-554C4CF9C27EQ59132146-D3C76D01-A2D7-46FE-9ADB-5CFDD82802D4
P2860
Glyco-engineering in plants to produce human-like N-glycan structures.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glyco-engineering in plants to produce human-like N-glycan structures.
@en
type
label
Glyco-engineering in plants to produce human-like N-glycan structures.
@en
prefLabel
Glyco-engineering in plants to produce human-like N-glycan structures.
@en
P2860
P356
P1476
Glyco-engineering in plants to produce human-like N-glycan structures.
@en
P2093
Alexandra Castilho
P2860
P304
P356
10.1002/BIOT.201200032
P577
2012-08-14T00:00:00Z